VisusNano
2 known investors
VisusNano develops ophthalmic drug delivery products, focusing on treatments for ocular and eye diseases. The company combines expertise in drug delivery, ophthalmic surgery, and clinical trials to create products for eye-care patients.
Founders & leadership
JG
Joanna GouldinChief Executive Officer
PA
Philip AlexanderinChief Medical Officer
DP
Darren PittinChief Scientific Officer
TK
Tom KempinChief Technology Officer
Board
PR
Paul RosenNon Executive Director
Investors Β· 2
Companies House Β· registry record
View on Companies House β- Registered name
- VISUSNANO LIMITED
- Company number
- 10116150
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 11 Apr 2016
- Registered office
- Camburgh House, 27 New Dover Road, Canterbury, Kent, CT1 3DN
- Nature of business (SIC)
- 72110 β Research and experimental development on biotechnology
- Accounts
- last made up to 30 Apr 2025 Β· next due 31 Jan 2027
- Confirmation statement
- last made up to 10 Apr 2026 Β· next due 24 Apr 2027
Current officers Β· 4
- Philip Alexander β director, appointed 11 Apr 2016
- David Ian Ford β director, appointed 1 Jun 2022
- Joanna Mary Gould β director, appointed 11 Apr 2016
- Paul Henry Rosen β director, appointed 1 Jan 2021
Source: Companies House public register Β· retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does VisusNano do?
- VisusNano develops ophthalmic drug delivery products, focusing on treatments for ocular and eye diseases. The company combines expertise in drug delivery, ophthalmic surgery, and clinical trials to create products for eye-care patients.
- Who are VisusNano's investors?
- VisusNano's investors include Innvotec Ltd., Oxford Investment Opportunity Network (OION).